Identifying a treatment for the novel coronavirus is perhaps the most vital scientific problem of the moment, particularly during the wait for a vaccine.
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.
China Petroleum & Chemical Corporation SNP, also known as Sinopec, reported fourth-quarter 2019 earnings per American Depositary Receipt (ADR) of $1.50. The bottom line was significantly higher than 30 cents per share reported a year ago owing to increased natural gas produc
American Express Co. AXP recently announced that even though it decides to stop any new employee hiring for this year but it will no way slash the existing jobs. This announcement came against the backdrop of the coronavirus-enforced business uncertainty.
Wall Street expects a year-over-year decline in earnings on higher revenues when Levi Strauss (LEVI) reports results for the quarter ended February 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that coul
Eli Lilly and Company LLY announced that the FDA has approved a supplemental biologics license application (sBLA) for its psoriasis drug Taltz (ixekizumab). Taltz injection (80 mg/mL) is now approved for the treatment of pediatric patients (aged from six to below 18 years) with
T-Mobile US, Inc. TMUS will have to secure an aggregate loan worth $23 billion from a group of 16 banks to successfully close its planned merger with Sprint Corp. S, per a Bloomberg report. The deal is planned to be closed as early as Apr 1. Notably, on Mar 19, T-Mobile announce
CLINIGEN GP PLC (CLIGF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investme
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.
Investors interested in Transportation - Airline stocks are likely familiar with Spirit (SAVE) and Alaska Air Group (ALK). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.